INS and metabolic syndrome: Illustratively, the insulin secretion signaling pathway emerges as a central orchestrator of glucose and lipid metabolism, with alterations in this pathway bearing direct consequences for the initiation and progression of cardiometabolic diseases, including obesity, T2D, and dyslipidemia.